Fetal bovine serum
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00292
- Awardee
-
Atlanta Biologicals, Inc. UEI ULFTKRGFBBA5 Part of Bio-Techne Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,655
Award facts
- Contract value 100% obligated
- $22,655.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Flowery Branch, GA, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc. for fetal bovine serum with a ceiling value of $22,655.10 on April 16, 2019, with completion scheduled for April 30, 2019. Performance occurs in Flowery Branch, Georgia. The order carries firm fixed pricing and no set-aside designation.
Quick answers
Who was awarded contract 75N91019P00292?
75N91019P00292 was awarded to Atlanta Biologicals, Inc. by National Cancer Institute (National Institutes of Health) on April 16, 2019.
How much is contract 75N91019P00292 worth?
The government has obligated $22,655 on 75N91019P00292.
Was contract 75N91019P00292 competed?
The extent of competition for 75N91019P00292 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award